These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 10430379

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of delayed administration of octreotide in acute experimental pancreatitis.
    Kaplan O, Kaplan D, Casif E, Siegal A, Paran H, Graf E, Skornick Y.
    J Surg Res; 1996 Apr; 62(1):109-17. PubMed ID: 8606496
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The significance of the dosage adjustment of octreotide in the treatment of acute pancreatitis of moderate severity.
    Nikou GC, Arnaoutis TP, Giamarellos-Bourboulis EJ, Samolada O, Vafiadis-Zouboulis I, Katsilambros N, Arvanitakis C.
    Hepatogastroenterology; 2001 Apr; 48(42):1754-7. PubMed ID: 11813617
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of somatostatin analogue and cholecystokinin receptor antagonist on bile-induced acute canine pancreatitis.
    Ko TC, Bertram MF, Prinz RA, Castelli M, Djuricin G, Jacobs HK.
    Am Surg; 1992 Apr; 58(4):213-9. PubMed ID: 1375011
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of prognostic factors in patients with acute pancreatitis.
    Brisinda G, Maria G, Ferrante A, Civello IM.
    Hepatogastroenterology; 1999 Apr; 46(27):1990-7. PubMed ID: 10430383
    [Abstract] [Full Text] [Related]

  • 12. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K, Weren M, Proesmans M, Kerem E.
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [Abstract] [Full Text] [Related]

  • 13. Controlled trial of different dosages of octreotide in the prevention of hyperamylasemia induced by endoscopic papillosphincterotomy.
    Testoni PA, Lella F, Bagnolo F, Buizza M, Colombo E.
    Ital J Gastroenterol; 1994 Dec; 26(9):431-6. PubMed ID: 7541258
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of octreotide (SMS 201-995) on experimentally induced pancreatitis with 50% ethyl alcohol in rats.
    Korun N, Yilmazlar T, Kaya E, Kutlay B.
    Int Surg; 1994 Dec; 79(2):148-51. PubMed ID: 7523326
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.
    Hesse UJ, Meester D, Troisi R, Cathenis K, Lameire N, Hemptinne B.
    Clin Transplant; 2005 Jun; 19(3):299-303. PubMed ID: 15877788
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Octreotide prevents L-asparaginase-induced pancreatic injury in rats.
    Suzuki M, Shimizu T, Kudo T, Shoji H, Ohtsuka Y, Yamashiro Y.
    Exp Hematol; 2008 Feb; 36(2):172-80. PubMed ID: 18023522
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.